American Science & Engineering (ASEI) 10-Q 9 Feb 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2015	Feb. 04, 2016
Document and Entity Information
Entity Registrant Name	AMERICAN SCIENCE & ENGINEERING, INC.
Entity Central Index Key	5,768
Document Type	10-Q
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		7,170,314
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
Current assets:
Cash and cash equivalents	$ 87,151	$ 68,835
Restricted cash	5,602	6,193
Short-term investments, at fair value	3,000	24,533
Accounts receivable, net of allowances of $283 and $333 at December 31, 2015 and March 31, 2015, respectively	13,723	22,124
Unbilled costs and fees	2,697	1,848
Inventories, net	39,561	40,983
Prepaid expenses and other current assets	9,580	10,701
Deferred income taxes	2,486	2,486
Total current assets	163,800	177,703
Equipment and leasehold improvements, net	6,425	8,711
Restricted cash	1,587	208
Deferred income taxes	5,952	5,952
Other assets	293	534
Total assets	178,057	193,108
Current liabilities:
Accounts payable	5,231	7,200
Accrued salaries and benefits	5,203	6,769
Accrued warranty costs	221	159
Deferred revenue	11,158	7,355
Customer deposits	12,076	13,956
Other current liabilities	2,985	5,736
Total current liabilities	36,874	41,175
Deferred revenue	1,861	1,019
Other long-term liabilities	676	507
Total liabilities	$ 39,411	$ 42,701
Stockholders' equity:
Preferred stock, no par value, 100,000 shares authorized; no shares issued
Common stock, $0.66 2/3 par value, 20,000,000 shares authorized; 7,167,424 and 7,193,247 shares issued and outstanding at December 31, 2015 and March 31, 2015, respectively	$ 4,778	$ 4,795
Capital in excess of par value	2,930	3,334
Accumulated other comprehensive loss, net	(7)	(11)
Retained earnings	130,945	142,289
Total stockholders' equity	138,646	150,407
Total liabilities and stockholders' equity	$ 178,057	$ 193,108

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, allowances (in dollars)	$ 283	$ 333
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.6666	$ 0.6666
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	7,167,424	7,193,247
Common stock, shares outstanding	7,167,424	7,193,247

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Net sales and contract revenues:
Net product sales and contract revenues	$ 9,730	$ 24,822	$ 42,296	$ 59,077
Net service revenues	12,443	12,158	36,458	36,506
Total net sales and contract revenues	22,173	36,980	78,754	95,583
Cost of sales and contracts:
Cost of product sales and contracts	5,104	14,040	22,769	32,869
Cost of service revenues	6,173	5,833	18,309	19,455
Total cost of sales and contracts	11,277	19,873	41,078	52,324
Gross profit	10,896	17,107	37,676	43,259
Expenses:
Selling, general and administrative expenses	7,693	7,627	22,735	24,936
Research and development costs	4,576	5,668	16,216	18,092
Total operating expenses	12,269	13,295	38,951	43,028
Operating income (loss)	(1,373)	3,812	(1,275)	231
Other income (expense):
Interest and investment income	30	54	119	219
Interest expense		(4)		(23)
Other expense, net	(52)	(32)	(317)	(284)
Total other expense	(22)	18	(198)	(88)
Income (loss) before provision for (benefit from) income taxes	(1,395)	3,830	(1,473)	143
Provision for (benefit from) income taxes	(931)	1,276	(958)	41
Net income (loss)	(464)	2,554	(515)	102
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale securities (net of tax)		(16)	4	(45)
Comprehensive income (loss)	$ (464)	$ 2,538	$ (511)	$ 57
Income (loss) per share - Basic (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Income (loss) per share - Diluted (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Weighted average shares - Basic (in shares)	7,164	7,789	7,158	7,866
Weighted average shares - Diluted (in shares)	7,164	7,796	7,158	7,877
Dividends declared per share (in dollars per share)	$ 0.50	$ 0.50	$ 1.50	$ 1.50

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ (515)	$ 102
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	2,882	3,624
Provisions for contracts, inventory and accounts receivable reserves	(5)	(237)
Amortization of bond premium	72	713
Deferred income taxes		1,993
Stock compensation expense	1,849	2,266
Other	202
Changes in assets and liabilities:
Accounts receivable	8,443	7,500
Unbilled costs and fees	(849)	(874)
Inventories	1,385	(9,138)
Prepaid expenses and other assets	1,362	(6,324)
Accounts payable	(1,969)	(3,868)
Accrued income taxes		(2,338)
Customer deposits	(1,880)	2,312
Deferred revenue	4,645	(1,781)
Accrued expenses and other liabilities	(4,086)	(7,917)
Net cash provided by (used for) operating activities	11,536	(13,967)
Cash flows from investing activities:
Purchases of short-term investments		(29,211)
Proceeds from sales and maturities of short-term investments	21,465	56,433
Purchases of property and equipment, net	(798)	(1,668)
Net cash provided by investing activities	20,667	25,554
Cash flows from financing activities:
(Increase) decrease in restricted cash	(788)	2,482
Proceeds from exercise of stock options		888
Repurchase of shares of common stock	(2,263)	(18,799)
Repayment of leasehold financing liability		(928)
Payment of common stock dividend	(10,836)	(11,948)
Increase in income taxes due to the tax impact of employee stock options		306
Net cash used for financing activities	(13,887)	(27,999)
Net increase (decrease) in cash and cash equivalents	18,316	(16,412)
Cash and cash equivalents at beginning of period	68,835	62,143
Cash and cash equivalents at end of period	$ 87,151	$ 45,731

GENERAL

GENERAL	9 Months Ended
	Dec. 31, 2015
GENERAL
GENERAL	1. GENERAL The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015. The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows. These results are not necessarily indicative of the results to be expected for the entire year. Nature of Operations The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications. The Company provides maintenance, warranty, engineering, and training and operator services related to these products. The Company has one reporting segment, X-ray detection solutions. Significant Accounting Policies For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met. Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method. The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015. There have been no changes to the Company’s critical accounting policies during the three and nine months December 31, 2015. Stock Repurchase Program On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions. On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock. During the nine months ended December 31, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86. The Company did not repurchase any shares of stock in the three months ended December 31, 2015. As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000. Dividends Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Dividends declared $ $ $ $ Dividends paid $ $ $ $ On February 8, 2016, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on March 2, 2016 to all shareholders of record at the close of business on February 18, 2016. Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant. Concentrations of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables. At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions. The Company’s credit risk is managed by investing its cash in money market funds, investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills and certificates of deposit. New Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers , which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items. Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements. In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory , which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In November 2015, the FASB issued ASU No. 2015-17, “ Balance Sheet Classification of Deferred Taxes (Topic 740 , which eliminates the current requirement for companies to present deferred tax liabilities and assets as current and non-current in a classified balance sheet. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016 (our fiscal year 2018), including interim periods within that reporting period. Early adoption is permitted as of the beginning of an interim or annual period. We are currently in the process of evaluating the impact of ASU 2015-17 on our financial position and results of operations.

ACCOUNTING FOR STOCK-BASED COMP

ACCOUNTING FOR STOCK-BASED COMPENSATION	9 Months Ended
	Dec. 31, 2015
ACCOUNTING FOR STOCK-BASED COMPENSATION
ACCOUNTING FOR STOCK-BASED COMPENSATION	2. ACCOUNTING FOR STOCK-BASED COMPENSATION The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB Accounting Standards Codification (“FASB ASC”) 718, Compensation—Stock Compensation , which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon the grant date fair value over the requisite service period for awards expected to vest. The Company recognized $805,000 and $496,000 of stock-based compensation costs for the three months ended December 31, 2015 and December 31, 2014, respectively. The Company recognized $1,849,000 and $2,266,000 of stock-based compensation costs for the nine months ended December 31, 2015 and December 31, 2014, respectively. The income tax benefit recognized related to the compensation costs for the three months ended December 31, 2015 and December 31, 2014 was approximately $282,000 and $223,000 respectively. The income tax benefit recognized related to the compensation costs for the nine months ended December 31, 2015 and December 31, 2014 was approximately $648,000 and $816,000, respectively. The following table summarizes stock-based compensation costs included in the Company’s consolidated statements of operations and comprehensive income (loss): Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Cost of sales and contracts $ $ $ $ Selling, general and administrative Total share-based compensation expense before tax $ $ $ $ Stock Option and Other Compensation Plans The Company has various stock option and other compensation plans for directors, officers, and employees. The Company had the following stock plans outstanding as of December 31, 2015: the 2005 Equity and Incentive Plan and the 2014 Equity and Incentive Plan. There are 366,000 shares remaining available for issuance under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years. Options under these plans are granted at fair market value and have a term of ten years from the date of grant. The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time that the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk-free interest rate is based on the U.S. Zero-Bond rate. Stock Options The following tables summarize stock option activity for the nine months ended December 31, 2015: Number of Shares Weighted Average Exercise Price ($) Weighted Average Contractual Life (years) Aggregate Intrinsic Value Options outstanding at March 31, 2015 $ Grants — — Exercises — — — Cancellations ) $ Options outstanding at December 31, 2015 $ Options exercisable at December 31, 2015 Information related to the stock options outstanding as of December 31, 2015 is as follows: Range of Exercise Prices Number of Shares Weighted- Average Remaining Contractual Life (years) Weighted- Average Exercise Price ($) Exercisable Number of Shares Exercisable Weighted- Average Exercise Price ($) $ 60.66-$69.99 $ $ $ 70.00-$75.82 $ 60.66-$75.82 $ $ There were no options granted in the three or nine months ended December 31, 2015. As of December 31, 2015, there was no remaining unrecognized compensation cost related to options granted. Restricted Stock and Restricted Stock Units The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock units, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred. Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years. In addition, annually the non-employee directors are granted restricted stock. Restricted stock shares granted to our non-employee directors vest on a pro-rata basis, based on service performed over the non-employee director’s one-year term of service. Certain of the stock and stock unit awards contain rights to receive non-forfeitable dividends. The fair values of the restricted stock and restricted stock unit awards are equal to the fair value of the Company’s common stock on the date of grant. Non-vested restricted stock and restricted stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of December 31, 2015, there was $5,546,000 of total unrecognized compensation costs related to non-vested restricted stock and restricted stock unit awards granted under the Company’s stock plans. These costs are expected to be recognized over a weighted average period of 1.55 years. The following table summarizes the status of the Company’s non-vested restricted stock and restricted stock unit awards for the nine months ended December 31, 2015: Number of Shares Weighted Average Grant Date Fair Value ($) Outstanding at March 31, 2015 $ Granted Vested ) Forfeited ) Outstanding at December 31, 2015 $

INVENTORIES

INVENTORIES	9 Months Ended
	Dec. 31, 2015
INVENTORIES
INVENTORIES	3. INVENTORIES Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred. The components of inventories at December 31, 2015 and March 31, 2015 were as follows: (In thousands) December 31, 2015 March 31, 2015 Raw materials, completed sub-assemblies, and spare parts $ $ Work-in-process Finished goods Total $ $

INCOME PER COMMON AND COMMON EQ

INCOME PER COMMON AND COMMON EQUIVALENT SHARE	9 Months Ended
	Dec. 31, 2015
INCOME PER COMMON AND COMMON EQUIVALENT SHARE
INCOME PER COMMON AND COMMON EQUIVALENT SHARE	4. INCOME PER COMMON AND COMMON EQUIVALENT SHARE Basic earnings per common share is computed by dividing distributed and undistributed earnings to common stockholders by the weighted average number of shares of common stock outstanding during the period. Share-based payment awards entitling holders to receive non-forfeitable dividends before vesting are considered participating securities and thus are included in the calculation of basic earnings per share under the two-class method. Diluted earnings per share include the dilutive impact of options, and restricted stock units using the average share price of the Company’s common stock for the period. For the three months ended December 31, 2015 and December 31, 2014, common stock equivalents of 331,000 and 244,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. For the nine months ended December 31, 2015 and December 31, 2014, common stock equivalents of 358,000 and 209,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. Three Months Ended Nine Months Ended (In thousands except per share amounts) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Income (Loss) Per Share — Basic: Net income (loss) $ ) $ $ ) $ Less: Distributed and undistributed earnings (loss) to unvested restricted stock units ) ) ) ) Distributed and undistributed earnings (loss) to common shareholders — basic ) ) Weighted average number of common shares outstanding — basic Net income (loss) per share — basic $ ) $ $ ) $ Diluted: Weighted average number of common shares outstanding Add dilutive effect of potential common shares — — Weighted average number of common and potential common shares outstanding — diluted Net income (loss) per share — diluted $ ) $ $ ) $

LETTERS OF CREDIT

LETTERS OF CREDIT	9 Months Ended
	Dec. 31, 2015
LETTERS OF CREDIT
LETTERS OF CREDIT	5. LETTERS OF CREDIT In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which management believes is low. As of December 31, 2015, the Company had outstanding $13,409,000 in standby letters of credit. These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $7,189,000 at December 31, 2015, of which $1,587,000 was considered long-term restricted cash and investments due to the expiration date of the underlying letters of credit.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Dec. 31, 2015
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	6. FAIR VALUE MEASUREMENTS The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument. Financial assets are categorized based on the inputs to the valuation techniques as follows: Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities). Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following: · Quoted prices for identical or similar assets or liabilities in non-active markets; · Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and · Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability. Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities. The following table presents the financial assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of December 31, 2015 and March 31, 2015: (In thousands) December 31, 2015 March 31, 2015 Level 1 — Financial Assets Money market funds $ $ Treasury bills — Total Level 1 Financial Assets Level 2 — Financial Assets Corporate debentures/bonds Government agency bonds — Total Level 2 Financial Assets Total cash equivalents and short-term investments $ $ Short-term investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of December 31, 2015, all of the Company’s available-for-sale securities had contractual maturities of seven months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three and nine months ended December 31, 2015 and December 31, 2014. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income (loss), as disclosed in the condensed consolidated statements of operations and comprehensive income (loss). (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value December 31, 2015: Short-term investments: Corporate debentures/bonds $ $ — $ — $ Total short-term investments $ $ — $ — $ Cash equivalents: Money market funds $ $ — $ — $ Total cash equivalents $ $ — $ — $ (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value March 31, 2015: Short-term investments: Corporate debentures/bonds $ $ — $ ) $ Government agency bonds — Treasury bills — Total short-term investments $ $ $ ) $ Cash equivalents: Money market funds $ $ — $ — $ Total cash equivalents $ $ — $ — $

INCOME TAXES

INCOME TAXES	9 Months Ended
	Dec. 31, 2015
INCOME TAXES
INCOME TAXES	7. INCOME TAXES The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes, and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at period end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized. In December 2015, the Research and Experimentation Credit, as defined by Internal Revenue Code Section 41(the “R&D Tax Credit”), was reinstated retroactively to January 1, 2015. Due to this retroactive reinstatement, there was a significant impact on the rate, for both the quarter and year to date. The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2013 through 2015 and by various state taxing authorities for the years ending March 31, 2012 through 2015.

GUARANTEES

GUARANTEES	9 Months Ended
	Dec. 31, 2015
GUARANTEES
GUARANTEES	8. GUARANTEES Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery. Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure. Warranty experience for the three and nine months December 31, 2015 and 2014 was as follows: Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Warranty accrual - beginning of period $ $ $ $ Accruals for warranties issued during the period Adjustment of preexisting accrual estimates ) ) ) ) Warranty costs incurred during the period ) ) ) ) Warranty accrual — end of period $ $ $ $

LEASE COMMITMENTS

LEASE COMMITMENTS	9 Months Ended
	Dec. 31, 2015
LEASE COMMITMENTS
LEASE COMMITMENTS	9. LEASE COMMITMENTS In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts. As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space. The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases. In October 2014, the Company entered into an amendment of its lease agreement for the Billerica facilities extending the term of the lease through February 28, 2023 with an adjusted rent schedule commencing October 1, 2014. Due to certain provisions of the amended lease agreements which removed certain continuing financing obligations related to the building, it was determined that the lease no longer qualified as a capital lease and as such, the Company removed the capitalized building, associated accumulated depreciation and lease financing liability from its books. The associated gain of $381,000 resulting from the removal of the building from our books was deferred and is being amortized over the modified lease term of the property.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2015
COMMITMENTS AND CONTINGENCIES.
COMMITMENTS AND CONTINGENCIES	10. COMMITMENTS AND CONTINGENCIES Deferred Revenue The Company offers extended warranty and service contracts to its customers. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of sales and contracts as incurred. Legal Matters The Company continues to cooperate with the Office of the Inspector General (“OIG”) of the U.S. General Services Administration (“GSA”) with respect to a subpoena issued on April 17, 2015 and a related investigation being conducted in conjunction with the Department of Defense. The investigation relates to the Company’s discount practices and compliance with the pricing provisions of the Company’s GSA Schedule contract. AS&E produced responsive materials to the GSA OIG from May 2015 through November 2015. The Company continues to cooperate fully with the investigation and at this time management is unable to predict the outcome of the investigation or estimate the amount of possible loss or range of loss with any certainty. It is possible that the investigation could lead to claims or findings of violations of the False Claims Act in connection with the Company’s GSA contracting activity. Violations of the False Claims Act could result in the imposition of damages, including up to treble damages, plus civil penalties in some cases. The Company has incurred, and will continue to incur, legal costs in connection with the investigation, and could incur other costs, damages or penalties, depending on its outcome, which could be material.

SUBSEQUENT EVENT

SUBSEQUENT EVENT	9 Months Ended
	Dec. 31, 2015
SUBSEQUENT EVENT
SUBSEQUENT EVENT	11. SUBSEQUENT EVENT On February 8, 2016, the Company commenced a cost reduction plan to reduce operating expenses . In connection with this plan, the Company initiated a workforce reduction. The reduction in workforce affected workers across all business areas of the business. Affected employees are entitled to receive certain severance and other benefits consistent with their position and tenure with the Company. The majority of the workforce reduction is expected to be completed by March 31, 2016. In connection with the reduction, the Company expect to record a charge of approximately $1.6 million to $1.8 million in the fourth quarter fiscal 2016.

GENERAL (Policies)

GENERAL (Policies)	9 Months Ended
	Dec. 31, 2015
GENERAL
Nature of Operations and Basis of Presentation	The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015. The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows. These results are not necessarily indicative of the results to be expected for the entire year. Nature of Operations The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications. The Company provides maintenance, warranty, engineering, and training and operator services related to these products. The Company has one reporting segment, X-ray detection solutions.
Revenue Recognition	Significant Accounting Policies For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met. Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method. The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015. There have been no changes to the Company’s critical accounting policies during the three and nine months December 31, 2015.
Stock Repurchase Program and Dividends	Stock Repurchase Program On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions. On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock. During the nine months ended December 31, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86. The Company did not repurchase any shares of stock in the three months ended December 31, 2015. As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000. Dividends Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Dividends declared $ $ $ $ Dividends paid $ $ $ $ On February 8, 2016, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on March 2, 2016 to all shareholders of record at the close of business on February 18, 2016. Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables. At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions. The Company’s credit risk is managed by investing its cash in money market funds, investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills and certificates of deposit.
New Accounting Pronouncements	New Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers , which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items. Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements. In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory , which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In November 2015, the FASB issued ASU No. 2015-17, “ Balance Sheet Classification of Deferred Taxes (Topic 740 , which eliminates the current requirement for companies to present deferred tax liabilities and assets as current and non-current in a classified balance sheet. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016 (our fiscal year 2018), including interim periods within that reporting period. Early adoption is permitted as of the beginning of an interim or annual period. We are currently in the process of evaluating the impact of ASU 2015-17 on our financial position and results of operations.

GENERAL (Tables)

GENERAL (Tables)	9 Months Ended
	Dec. 31, 2015
GENERAL
Schedule of dividends	Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Dividends declared $ $ $ $ Dividends paid $ $ $ $

ACCOUNTING FOR STOCK-BASED CO19

ACCOUNTING FOR STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Dec. 31, 2015
ACCOUNTING FOR STOCK-BASED COMPENSATION
Summary of stock-based compensation costs in the statements of operations and comprehensive income (loss)	Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Cost of sales and contracts $ $ $ $ Selling, general and administrative Total share-based compensation expense before tax $ $ $ $
Summary of stock option activity	Number of Shares Weighted Average Exercise Price ($) Weighted Average Contractual Life (years) Aggregate Intrinsic Value Options outstanding at March 31, 2015 $ Grants — — Exercises — — — Cancellations ) $ Options outstanding at December 31, 2015 $ Options exercisable at December 31, 2015
Schedule of information related to stock options by exercise price range	Information related to the stock options outstanding as of December 31, 2015 is as follows: Range of Exercise Prices Number of Shares Weighted- Average Remaining Contractual Life (years) Weighted- Average Exercise Price ($) Exercisable Number of Shares Exercisable Weighted- Average Exercise Price ($) $ 60.66-$69.99 $ $ $ 70.00-$75.82 $ 60.66-$75.82 $ $
Summary of the status of the non-vested restricted stock and stock unit awards	Number of Shares Weighted Average Grant Date Fair Value ($) Outstanding at March 31, 2015 $ Granted Vested ) Forfeited ) Outstanding at December 31, 2015 $

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Dec. 31, 2015
INVENTORIES
Schedule of components of inventories	(In thousands) December 31, 2015 March 31, 2015 Raw materials, completed sub-assemblies, and spare parts $ $ Work-in-process Finished goods Total $ $

INCOME PER COMMON AND COMMON 21

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Tables)	9 Months Ended
	Dec. 31, 2015
INCOME PER COMMON AND COMMON EQUIVALENT SHARE
Schedule of calculation of basic and diluted earnings per share	Three Months Ended Nine Months Ended (In thousands except per share amounts) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Income (Loss) Per Share — Basic: Net income (loss) $ ) $ $ ) $ Less: Distributed and undistributed earnings (loss) to unvested restricted stock units ) ) ) ) Distributed and undistributed earnings (loss) to common shareholders — basic ) ) Weighted average number of common shares outstanding — basic Net income (loss) per share — basic $ ) $ $ ) $ Diluted: Weighted average number of common shares outstanding Add dilutive effect of potential common shares — — Weighted average number of common and potential common shares outstanding — diluted Net income (loss) per share — diluted $ ) $ $ ) $

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Dec. 31, 2015
FAIR VALUE MEASUREMENTS
Schedule of financial assets measured at fair value on recurring basis, based on the fair value hierarchy	(In thousands) December 31, 2015 March 31, 2015 Level 1 — Financial Assets Money market funds $ $ Treasury bills — Total Level 1 Financial Assets Level 2 — Financial Assets Corporate debentures/bonds Government agency bonds — Total Level 2 Financial Assets Total cash equivalents and short-term investments $ $
Schedule of available-for-sale securities	(In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value December 31, 2015: Short-term investments: Corporate debentures/bonds $ $ — $ — $ Total short-term investments $ $ — $ — $ Cash equivalents: Money market funds $ $ — $ — $ Total cash equivalents $ $ — $ — $ (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value March 31, 2015: Short-term investments: Corporate debentures/bonds $ $ — $ ) $ Government agency bonds — Treasury bills — Total short-term investments $ $ $ ) $ Cash equivalents: Money market funds $ $ — $ — $ Total cash equivalents $ $ — $ — $

GUARANTEES (Tables)

GUARANTEES (Tables)	9 Months Ended
	Dec. 31, 2015
GUARANTEES
Schedule of warranty experience	Three Months Ended Nine Months Ended (In thousands) December 31, 2015 December 31, 2014 December 31, 2015 December 31, 2014 Warranty accrual - beginning of period $ $ $ $ Accruals for warranties issued during the period Adjustment of preexisting accrual estimates ) ) ) ) Warranty costs incurred during the period ) ) ) ) Warranty accrual — end of period $ $ $ $

GENERAL - REPORTING SEGMENTS (D

GENERAL - REPORTING SEGMENTS (Details)	9 Months Ended
	Dec. 31, 2015segment
Nature of Operations
Number of reporting segments	1

GENERAL - STOCK REPURCHASE PROG

GENERAL - STOCK REPURCHASE PROGRAM (Details) - USD ($)	Mar. 02, 2016	Feb. 08, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 01, 2014	May. 07, 2013
Dividends
Dividends declared (in dollars per share)		$ 0.50	$ 0.50	$ 0.50	$ 1.50	$ 1.50
Dividends paid (in dollars per share)			$ 0.50	$ 0.50	$ 1.50	$ 1.50
Forecast
Dividends
Dividends paid (in dollars per share)	$ 0.50
Stock Repurchase Program
Stock Repurchase Program
Number of shares repurchased under the stock repurchase program			0		54,056
Average price of shares repurchased					$ 41.86
Maximum dollar value of shares that may still be purchased under stock repurchase program			$ 11,225,000		$ 11,225,000
Fifth Stock Repurchase Program
Stock Repurchase Program
Authorized amount of repurchase of common stock							$ 50,000,000	$ 35,000,000

ACCOUNTING FOR STOCK-BASED CO26

ACCOUNTING FOR STOCK-BASED COMPENSATION - COST SUMMARY (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Stock-based compensation cost
Share-based compensation expense before tax	$ 805,000	$ 496,000	$ 1,849,000	$ 2,266,000
Income tax benefit recognized related to the compensation costs	282,000	223,000	648,000	816,000
Cost of sales and contracts
Stock-based compensation cost
Share-based compensation expense before tax	176,000	124,000	289,000	647,000
Selling, general and administrative expenses
Stock-based compensation cost
Share-based compensation expense before tax	$ 629,000	$ 372,000	$ 1,560,000	$ 1,619,000

ACCOUNTING FOR STOCK-BASED CO27

ACCOUNTING FOR STOCK-BASED COMPENSATION - ACTIVITY (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2015	Mar. 31, 2015
Stock Option and Other Compensation Plans
Number of shares that remain available for future issuance under the plans	366,000	366,000
Minimum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		1 year
Maximum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		3 years
Stock options
Stock Option and Other Compensation Plans
Term of awards from the date of grant		10 years
Number of Shares
Options outstanding at the beginning of the period (in shares)		191,834
Grants (in shares)	0	0
Cancellations (in shares)		(51,901)
Options outstanding at the end of the period (in shares)	139,933	139,933	191,834
Options exercisable at the end of the period (in shares)	139,933	139,933
Weighted Average Exercise Price
Options outstanding at the beginning of the period (in dollars per share)		$ 66.03
Cancellations (in dollars per share)		59.34
Options outstanding at the end of the period (in dollars per share)	$ 68.51	$ 68.51	$ 66.03
Weighted Average Contractual Life
Options outstanding at the end of the period		2 years 9 months 29 days	2 years 10 months 17 days
Remaining unrecognized compensation cost (in dollars)	$ 0	$ 0

ACCOUNTING FOR STOCK-BASED CO28

ACCOUNTING FOR STOCK-BASED COMPENSATION - STOCK OPTIONS OUTSTANDING (Details) - Stock options	9 Months Ended
	Dec. 31, 2015$ / sharesshares
$60.66-$69.99
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	$ 60.66
Exercise price, high end of range (in dollars per share)	$ 69.99
Number of Shares | shares	83,752
Weighted-Average Remaining Contractual Life	2 years 2 months 12 days
Weighted-Average Exercise Price (in dollars per share)	$ 64.24
Exercisable Number of Shares | shares	83,752
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 64.24
$70.00-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	70
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	56,181
Weighted-Average Remaining Contractual Life	3 years 9 months 7 days
Weighted-Average Exercise Price (in dollars per share)	$ 74.87
Exercisable Number of Shares | shares	56,181
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 74.87
$60.66-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	60.66
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	139,933
Weighted-Average Remaining Contractual Life	2 years 9 months 29 days
Weighted-Average Exercise Price (in dollars per share)	$ 68.51
Exercisable Number of Shares | shares	139,933
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 68.51

ACCOUNTING FOR STOCK-BASED CO29

ACCOUNTING FOR STOCK-BASED COMPENSATION - NON-VESTED AND RESTERICTED STOCK UNITS (Details)	9 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock and Restricted Stock Units
Stockholder's equity
Unrecognized compensation costs (in dollars) | $	$ 5,546,000
Expected period to recognize unrecognized compensation costs	1 year 6 months 18 days
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	91,837
Granted (in shares) | shares	120,439
Vested (in shares) | shares	(23,347)
Forfeited (in shares) | shares	(7,838)
Outstanding at the end of the period (in shares) | shares	181,091
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 62.99
Granted (in dollars per share) | $ / shares	43.74
Vested (in dollars per share) | $ / shares	55.65
Forfeited (in dollars per share) | $ / shares	63.65
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 51.11
Restricted Stock and Restricted Stock Units | Employees | Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Restricted Stock and Restricted Stock Units | Employees | Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock | Non-employee directors
Stockholder's equity
Vesting period for awards granted under the plans	1 year

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
INVENTORIES
Raw materials, completed sub-assemblies, and spare parts	$ 21,372	$ 20,334
Work-in-process	14,788	17,853
Finished goods	3,401	2,796
Total	$ 39,561	$ 40,983

INCOME PER COMMON AND COMMON 31

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
INCOME PER COMMON AND COMMON EQUIVALENT SHARE
Common stock equivalents excluded from diluted earnings per share as their effect is anti-dilutive (in shares)	331,000	244,000	358,000	209,000
Income (Loss) Per Share - Basic:
Net income (loss)	$ (464)	$ 2,554	$ (515)	$ 102
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	(1)	(27)	(11)	(4)
Distributed and undistributed earnings (loss) to common shareholders	$ (465)	$ 2,527	$ (526)	$ 98
Weighted average number of common shares outstanding (in shares)	7,164,000	7,789,000	7,158,000	7,866,000
Net income (loss) per share - basic (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Diluted:
Weighted average number of common shares outstanding (in shares)	7,164,000	7,789,000	7,158,000	7,866,000
Add dilutive effect of potential common shares (in shares)		7,000		11,000
Weighted average number of common and potential common shares outstanding - diluted (in shares)	7,164,000	7,796,000	7,158,000	7,877,000
Net income (loss) per share - diluted (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01

LETTERS OF CREDIT (Details)

LETTERS OF CREDIT (Details) - USD ($)	Dec. 31, 2015	Mar. 31, 2015
Credit facilities
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 1,587,000	$ 208,000
Standby letters of credit
Credit facilities
Outstanding Amount	13,409,000
Restricted cash balance	7,189,000
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 1,587,000
Standby letters of credit | Minimum
Credit facilities
Percentage of outstanding amount that is cash secured	52.00%
Standby letters of credit | Maximum
Credit facilities
Percentage of outstanding amount that is cash secured	63.00%

FAIR VALUE MEASUREMENTS - FINAN

FAIR VALUE MEASUREMENTS - FINANCIAL ASSETS (Details) - Recurring basis - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
Total fair value
Financial Assets
Total cash equivalents and short-term investments	$ 66,485	$ 76,317
Level 1
Financial Assets
Total cash equivalents and short-term investments	63,485	57,187
Level 1 | Treasury bills
Financial Assets
Total cash equivalents and short-term investments		5,403
Level 1 | Money market funds
Financial Assets
Total cash equivalents and short-term investments	63,485	51,784
Level 2
Financial Assets
Total cash equivalents and short-term investments	3,000	19,130
Level 2 | Corporate debentures/bonds
Financial Assets
Total cash equivalents and short-term investments	$ 3,000	13,813
Level 2 | Government agency bonds
Financial Assets
Total cash equivalents and short-term investments		$ 5,317

FAIR VALUE MEASUREMENTS - AVAIL

FAIR VALUE MEASUREMENTS - AVAILABLE-FOR-SALE SECURITIES (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2015	Mar. 31, 2015
Maximum
Available-for-sale securities
Contractual maturity period	7 months
Short-term investments.
Available-for-sale securities
Amortized Cost	$ 3,000	$ 24,538
Gross Unrealized Gains		5
Gross Unrealized Losses		(10)
Fair Value	3,000	24,533
Short-term investments. | Corporate debentures/bonds
Available-for-sale securities
Amortized Cost	3,000	13,823
Gross Unrealized Losses		(10)
Fair Value	3,000	13,813
Short-term investments. | Government agency bonds
Available-for-sale securities
Amortized Cost		5,315
Gross Unrealized Gains		2
Fair Value		5,317
Short-term investments. | Treasury bills
Available-for-sale securities
Amortized Cost		5,400
Gross Unrealized Gains		3
Fair Value		5,403
Cash equivalents
Available-for-sale securities
Amortized Cost	63,485	51,784
Fair Value	63,485	51,784
Cash equivalents | Money market funds
Available-for-sale securities
Amortized Cost	63,485	51,784
Fair Value	$ 63,485	$ 51,784

INCOME TAXES (Details)

INCOME TAXES (Details)	9 Months Ended
	Dec. 31, 2015
INCOME TAXES
Number of years of cumulative income based upon which valuation allowance is evaluated	3 years

GUARANTEES (Details)

GUARANTEES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
GUARANTEES
Warranty period for certain products			1 year
Historical experience trailing period based on how product warranty accrual rates are determined			12 months
Warranty Experience
Warranty accrual at beginning of period	$ 200	$ 186	$ 159	$ 404
Accruals for warranties issued during the period	107	99	281	184
Adjustment of preexisting accrual estimates	(62)	(42)	(26)	(202)
Warranty costs incurred during period	(24)	(61)	(193)	(204)
Warranty accrual at end of period	$ 221	$ 182	$ 221	$ 182

LEASE COMMITMENTS (Details)

LEASE COMMITMENTS (Details)	Oct. 31, 2014USD ($)
LEASE COMMITMENTS
Gain deferred from the removal of building	$ 381,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	9 Months Ended
	Dec. 31, 2015
COMMITMENTS AND CONTINGENCIES.
Minimum period covered under extended warranty and service contracts	1 year
Maximum period covered under extended warranty and service contracts	5 years

SUBSEQUENT EVENT (Details)

SUBSEQUENT EVENT (Details) - Subsequent Event. - Forecast $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)
Minimum
Severance and other charges
Expected charge	$ 1.6
Maximum
Severance and other charges
Expected charge	$ 1.8